MDW Capital advises A&M Capital Europe on raising debt facilities to support its majority acquisition of GBUK Limited

 

London, 10 January 2024

 

MDW Capital is pleased to announce the completion of its latest transaction.  The Firm has advised A&M Capital Europe (“AMCE”) on arranging debt facilities to support AMCE’s majority acquisition of GBUK Limited (“GBUK”), a global leader in providing cutting-edge medical devices and services.  The transaction also marks the end of another record year for MDW, with the Firm completing 15 transactions and advising on £1 billion of debt facilities in 2023.

Headquartered in the United Kingdom, GBUK designs, develops, manufactures and distributes a comprehensive portfolio of own and third party branded acute-setting medical devices across enteral feeding, vascular access, patient handling and the broader critical care environment.  The Company is a top 20 supplier to the NHS, supporting healthcare professionals and patients in 45+ countries globally with more than 600,000 medical devices a day.  GBUK has demonstrated a track-record of penetrating new care areas by leveraging its R&D capabilities and a high-touch sales model hinging around wrap-around services. 

AMCE, a leading European private equity investor specialising in building pan-European platform companies through buy-and-build in the middle market, engaged MDW Capital to advise on securing a financing package to support its investment.

Stefan Miesner, Director at AMCE commented “GBUK is our second UK investment of 2023 and represents an exciting platform to build a market leading global Medtech business.  Getting the right debt advice to support the acquisition was critical so we engaged MDW. The deep involvement of the MDW team alongside the hands-on engagement by the deal partner resulted in a tailored debt solution to support our acquisition.” 

David Culpan, Managing Partner at MDW Capital added “In order to deliver excellent debt advisory services to our clients, it is absolutely critical to think like an investor and understand each investor’s key objectives.  As our clients have previously stated, our experience as shareholders and borrowers clearly differentiates MDW and delivers the debt facilities that match our client’s needs.  This transaction is our 15th completion of 2023, seeing the Firm advise on £1 billion of debt facilities and continuing to build the team.  We look forward to continuing to deliver further completions and develop the MDW business and team in 2024.”